CpG methylation of APC promoter 1A in sporadic and familial breast cancer patients.
暂无分享,去创建一个
Mounir Frikha | Jamel Daoud | A. Khabir | T. Sellami-Boudawara | J. Daoud | M. Frikha | R. Mokdad-Gargouri | Abdelmajid Khabir | Tahia Sellami-Boudawara | Raja Mokdad-Gargouri | Saoussen Debouki-Joudi | Fatma Trifa | F. Trifa | Saoussen Debouki-Joudi
[1] A. Neugut,et al. Gene promoter methylation is associated with increased mortality among women with breast cancer , 2009, Breast Cancer Research and Treatment.
[2] J. Herman,et al. Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. , 2000, Cancer research.
[3] T. Motoyama,et al. Adenomatous polyposis coli (APC) gene promoter hypermethylation in primary breast cancers , 2001, British Journal of Cancer.
[4] A. Khabir,et al. Clinical Significance of Epigenetic Inactivation of hMLH1 and BRCA1 in Tunisian Patients with Invasive Breast Carcinoma , 2009, Journal of biomedicine & biotechnology.
[5] R. Brentani,et al. Loss of heterozygosity affecting the APC and MCC genetic loci in patients with primary breast carcinomas. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[6] S. Mirza,et al. Epigenetic alterations of CDH1 and APC genes: relationship with activation of Wnt/beta-catenin pathway in invasive ductal carcinoma of breast. , 2008, Life sciences.
[7] A. Neugut,et al. BRCA1 promoter methylation is associated with increased mortality among women with breast cancer , 2009, Breast Cancer Research and Treatment.
[8] J. Minna,et al. Promoter hypermethylation in benign breast epithelium in relation to predicted breast cancer risk. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.
[9] E. Robertson,et al. Epigenetic Regulation of Tumor Suppressors by Helicobacter pylori Enhances EBV-Induced Proliferation of Gastric Epithelial Cells , 2018, mBio.
[10] A. Wyllie,et al. Allele loss from 5q21 (APC/MCC) and 18q21 (DCC) and DCC mRNA expression in breast cancer. , 1993, British Journal of Cancer.
[11] A. Cheung,et al. Detection of hypermethylated genes in tumor and plasma of cervical cancer patients. , 2004, Gynecologic oncology.
[12] S. Altschul,et al. Identification of FAP locus genes from chromosome 5q21. , 1991, Science.
[13] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.
[14] R Kemler,et al. beta-catenin is a target for the ubiquitin-proteasome pathway. , 1997, The EMBO journal.
[15] R. Moon,et al. The APC tumor suppressor protein in development and cancer. , 1997, Trends in genetics : TIG.
[16] F. C. Lucibello,et al. Localization of the gene for familial adenomatous polyposis on chromosome 5 , 1987, Nature.
[17] P. Laird. Early detection: The power and the promise of DNA methylation markers , 2003, Nature Reviews Cancer.
[18] M. Taketo,et al. Adenomatous polyposis coli (APC): a multi-functional tumor suppressor gene , 2007, Journal of Cell Science.
[19] S Ichii,et al. Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. , 1992, Human molecular genetics.
[20] Hans Clevers,et al. Wnt/β-Catenin Signaling in Development and Disease , 2006, Cell.
[21] M. Swellam,et al. Aberrant methylation of APC and RARβ2 genes in breast cancer patients , 2015, IUBMB life.
[22] S. Nishizuka,et al. Distinct methylation patterns of two APC gene promoters in normal and cancerous gastric epithelia , 2000, Oncogene.
[23] R. Parsons,et al. APC truncation and increased beta-catenin levels in a human breast cancer cell line. , 2000, Carcinogenesis.
[24] K. Amara,et al. Evidence for a role of the Simian Virus 40 in human breast carcinomas , 2008, Breast Cancer Research and Treatment.
[25] Bert Vogelstein,et al. APC mutations occur early during colorectal tumorigenesis , 1992, Nature.
[26] P. Polakis,et al. Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[27] W F Bodmer,et al. The ABC of APC. , 2001, Human molecular genetics.
[28] J Herman,et al. Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[29] D. Sidransky,et al. Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer. , 2002, Cancer research.
[30] Å. Borg,et al. Involvement of adenomatous polyposis coli (APC)/β-catenin signalling in human breast cancer , 2000 .
[31] Margaret Robertson,et al. Identification and characterization of the familial adenomatous polyposis coli gene , 1991, Cell.
[32] Paul Cairns,et al. Tumor Suppressor Gene Promoter Hypermethylation in Serum of Breast Cancer Patients , 2004, Clinical Cancer Research.
[33] J. McPherson,et al. Identification of deletion mutations and three new genes at the familial polyposis locus , 1991, Cell.
[34] J. Jónasson,et al. Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer , 2006, Breast Cancer Research.
[35] B. Vogelstein,et al. A genetic model for colorectal tumorigenesis , 1990, Cell.
[36] David Sidransky,et al. Emerging molecular markers of cancer , 2002, Nature Reviews Cancer.
[37] W. Ballhausen,et al. Identification of an alternative 5′ untranslated region of the adenomatous polyposis coli gene , 1993, Human Genetics.
[38] B. X. Trinh,et al. Aberrant methylation of the Adenomatous Polyposis Coli (APC) gene promoter is associated with the inflammatory breast cancer phenotype , 2008, British Journal of Cancer.
[39] M. Tada,et al. Somatic mutations of the APC gene in primary breast cancers. , 2000, The American journal of pathology.
[40] Jörg Stappert,et al. β‐catenin is a target for the ubiquitin–proteasome pathway , 1997 .
[41] R. Parsons,et al. APC truncation and increased β-catenin levels in a human breast cancer cell line , 2000 .
[42] K. Kinzler,et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. , 1991, Science.
[43] H. Clevers. Wnt/beta-catenin signaling in development and disease. , 2006, Cell.
[44] Lam,et al. Reduced expression of APC and DCC gene protein in breast cancer , 1999, Histopathology.